Rocket Pharmaceuticals Inc (NASDAQ:RCKT)’s traded shares stood at 2.85 million during the last session, with the company’s beta value hitting 1.02. At the close of trading, the stock’s price was $7.86, to imply an increase of 3.01% or $0.23 in intraday trading. The RCKT share’s 52-week high remains $26.98, putting it -243.26% down since that peak but still an impressive 42.11% since price per share fell to its 52-week low of $4.55. The company has a valuation of $838.10M, with an average of 2.67 million shares in intraday trading volume over the past 10 days and average of 2.36 million shares over the past 3 months.
Analysts have given a consensus recommendation of Buy for Rocket Pharmaceuticals Inc (RCKT), translating to a mean rating of 1.12. Of 8 analyst(s) looking at the stock, 0 analyst(s) give RCKT a Sell rating. 0 of those analysts rate the stock as Overweight while 1 advise Hold as 7 recommend it as a Buy.
Rocket Pharmaceuticals Inc (NASDAQ:RCKT) trade information
After registering a 3.01% upside in the last session, Rocket Pharmaceuticals Inc (RCKT) has traded red over the past five days. The 5-day price performance for the stock is 5.79%, and 35.28% over 30 days. With these gigs, the year-to-date price performance is -37.47%. Short interest in Rocket Pharmaceuticals Inc (NASDAQ:RCKT) saw shorts transact 13.3 million shares and set a 3.74 days time to cover.
The extremes give us $32 and $39 for target low and target high price respectively. As such, RCKT has been trading -396.18% off suggested target high and -307.12% from its likely low.
An assessment of the company’s 5-year growth patterns shows that annual earnings shrunk an estimated -11.60% for the past 5-year period. While 2025 is set for a 10.72% return in earnings, projections for the next 5 years are at 60.19% annually.
RCKT Dividends
Rocket Pharmaceuticals Inc has its next earnings report out on 2025-Feb-26. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
Rocket Pharmaceuticals Inc (NASDAQ:RCKT)’s Major holders
Rocket Pharmaceuticals Inc insiders hold 3.03% of total outstanding shares, with institutional holders owning 107.73% of the shares at 111.09% float percentage. In total, 107.73% institutions holds shares in the company, led by RTW INVESTMENTS, LP. As of 2024-06-30, the company held over 17.69 million shares (or 18.8677% of shares), all amounting to roughly $380.82 million.
The next major institution holding the largest number of shares is WELLINGTON MANAGEMENT GROUP LLP with 9.16 million shares, or about 9.7665% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $197.12 million.
We also have VANGUARD SPECIALIZED FUNDS-Vanguard Health Care Fund and VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund as the top two Mutual Funds with the largest holdings of the Rocket Pharmaceuticals Inc (RCKT) shares. Going by data provided on Jan 31, 2025 , VANGUARD SPECIALIZED FUNDS-Vanguard Health Care Fund holds roughly 7.6 shares. This is just over 7.13% of the total shares, with a market valuation of $59.72 million. Data from the same date shows that the other fund manager holds a little less at 2.62, or 2.46% of the shares, all valued at about 20.61 million.
